Bob Langer-backed biotech plots $86M IPO as FDA filings loom
June 26, 2017 at 10:10 AM EDT
The eye drug developer, Kala Pharmaceuticals, is the third Massachusetts biotech to announce plans this month for an IPO.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|